Navigation Links
MyClyns(TM), a New Standard of Personal Protection, is Announced at the EMS and Firehouse Central EXPO
Date:10/10/2007

Union Springs Pharmaceutical launches the only non-alcohol first response

protection product that can be sprayed on the face.

ORLANDO, Fla., Oct. 10 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC, announced today at the annual EMS EXPO that it is marketing a new revolutionary product, MyClyns(TM). MyClyns is the first product of its kind to be made available to first responders who need to protect themselves in the field when exposed to harmful pathogens. The product, a small pen-sized non- aerosol spray device that can be kept in a pocket, is convenient and safe to use on the face and mucous membranes including the eyes, ears, nose, mouth, and skin. In addition, MyClyns is a fast-acting skin protectant that kills over 99.99% of germs on contact as demonstrated in independent laboratory tests. MyClyns also provides immediate efficacy after one application (>99% bacterial reduction) and passed the initial reduction criteria for the Health Care Personnel Handwash Test.

MyClyns contains a pH neutral, non-irritating solution of compounds that are similar to the chemicals produced by the human body in its defense against microorganisms. These compounds move through the pathogen's cells and deactivate essential enzymes and structures.

MyClyns allows first responders to protect themselves immediately after exposure to harmful pathogens while still attending to their care recipients. Since users can protect themselves immediately, they lower their risk associated with prolonged exposure. Because of its unique and convenient design, MyClyns can be used with only one hand. MyClyns is intended for use by police, fire, military, emergency medical personnel, healthcare providers, homeland security personnel and others.

Union Springs licensed worldwide rights to the Microcyn(R) Technology used in MyClyns for single-use first responder applications from Oculus Innovative Sciences, Inc. (Petaluma, CA) in June of this year.

"Our team at Union Springs is excited to be launching MyClyns at this year's EMS EXPO" said Roger Griggs, Chairman of Union Springs Pharmaceuticals. "We believe we have a truly unique product that first responders will use in situations where today there is nothing else available. We are happy to advance the science of personal protection and we hope that MyClyns will become the standard of care for first line responders after exposures where immediate attention is required," he added.

About Union Springs Pharmaceuticals, LLC

Union Springs Pharmaceuticals, located in Union, KY, specializes in providing innovative over-the-counter (OTC) products for the consumer and healthcare markets. The company licenses, acquires, develops and commercializes innovative products and technologies that satisfy the unmet needs of healthcare professionals and consumers. Union Springs Pharmaceuticals was formed by the Drug Enhancement Company of America (DECA) to commercialize products specifically targeted for the OTC market. DECA and members of its management team have developed both prescription and over-the-counter healthcare products and services and companies including Richwood Pharmaceuticals (now Shire), Xanodyne Pharmaceuticals, Integrity Pharmaceuticals, PediaMed and Hill Top Research. For more information about DECA, please visit http://www.decausa.com. Union Springs Pharmaceuticals can be found on the Internet at http://www.unionspringspharmaceuticals.com

Microcyn(R) is a registered trademark of Oculus Innovative Sciences, Inc.


'/>"/>
SOURCE Union Springs Pharmaceuticals, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Brinkmann/Eppendorf SOP Standard Operating Procedure for Pipettes
2. BioRobot MDx standardize your automated protocols in clinical laboratories
3. Thermal Cycling Profile for Standard PCR
4. Quantitative end-point RT-PCR gene expression measurement using the Agilent 2100 Bioanalyzer and standardized RT-PCR
5. Selection of Standards for Bio-Plex Cytokine Assays, Rev A
6. Universal Guide to DNA Standards
7. Verifying Multichannel Pipettor Performance with Standard Dispense Solutions in the SpectraMax Plus (MaxLine Application Note #28)
8. Accurate Evaluation of the Finnigan Surveyor Autosampler Performance using a Deferred Standard
9. Federal bill would set healthcare IT standards
10. Wisconsin firms pledge to support healthcare IT standards
11. Doyle, Kind call for higher renewable fuel standard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
Breaking Biology Technology:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
Breaking Biology News(10 mins):